KR20190035139A - A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof - Google Patents
A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof Download PDFInfo
- Publication number
- KR20190035139A KR20190035139A KR1020170124018A KR20170124018A KR20190035139A KR 20190035139 A KR20190035139 A KR 20190035139A KR 1020170124018 A KR1020170124018 A KR 1020170124018A KR 20170124018 A KR20170124018 A KR 20170124018A KR 20190035139 A KR20190035139 A KR 20190035139A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- composition
- beverage
- present
- food
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 94
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 235000013305 food Nutrition 0.000 title claims abstract description 22
- 235000013361 beverage Nutrition 0.000 title claims abstract description 20
- 238000000034 method Methods 0.000 title claims description 34
- 206010019133 Hangover Diseases 0.000 title abstract description 15
- 244000194828 Ligularia tussilaginea Species 0.000 title 1
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 26
- 239000004480 active ingredient Substances 0.000 claims abstract description 15
- 239000002537 cosmetic Substances 0.000 claims abstract description 14
- 230000003908 liver function Effects 0.000 claims abstract description 10
- 230000000694 effects Effects 0.000 claims description 21
- 240000008397 Ganoderma lucidum Species 0.000 claims description 20
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 15
- YLJREFDVOIBQDA-UHFFFAOYSA-N tacrine Chemical compound C1=CC=C2C(N)=C(CCCC3)C3=NC2=C1 YLJREFDVOIBQDA-UHFFFAOYSA-N 0.000 claims description 14
- 229960001685 tacrine Drugs 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 12
- 206010067125 Liver injury Diseases 0.000 claims description 10
- 231100000234 hepatic damage Toxicity 0.000 claims description 10
- 230000008818 liver damage Effects 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 9
- 239000000839 emulsion Substances 0.000 claims description 8
- 239000000725 suspension Substances 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 6
- 239000006210 lotion Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 239000003921 oil Substances 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- 235000019219 chocolate Nutrition 0.000 claims description 4
- 239000000499 gel Substances 0.000 claims description 4
- 239000012046 mixed solvent Substances 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 244000269722 Thea sinensis Species 0.000 claims description 3
- 235000013334 alcoholic beverage Nutrition 0.000 claims description 3
- 235000015243 ice cream Nutrition 0.000 claims description 3
- 235000013372 meat Nutrition 0.000 claims description 3
- 235000012149 noodles Nutrition 0.000 claims description 3
- 239000006072 paste Substances 0.000 claims description 3
- 235000013550 pizza Nutrition 0.000 claims description 3
- 235000013616 tea Nutrition 0.000 claims description 3
- 235000015872 dietary supplement Nutrition 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 2
- 240000000513 Santalum album Species 0.000 claims 1
- 235000008632 Santalum album Nutrition 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 9
- 241001146192 Ligularia stenocephala Species 0.000 abstract description 5
- 235000013402 health food Nutrition 0.000 abstract description 4
- 206010019851 Hepatotoxicity Diseases 0.000 abstract description 2
- 231100000304 hepatotoxicity Toxicity 0.000 abstract description 2
- 230000007686 hepatotoxicity Effects 0.000 abstract description 2
- 208000019423 liver disease Diseases 0.000 abstract description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 210000003494 hepatocyte Anatomy 0.000 description 16
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 238000002835 absorbance Methods 0.000 description 13
- 230000002292 Radical scavenging effect Effects 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- 235000013824 polyphenols Nutrition 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 7
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 7
- 241000222336 Ganoderma Species 0.000 description 7
- 229930003935 flavonoid Natural products 0.000 description 7
- 235000017173 flavonoids Nutrition 0.000 description 7
- 150000002215 flavonoids Chemical class 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- -1 fractions Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241001672694 Citrus reticulata Species 0.000 description 4
- 244000010000 Hovenia dulcis Species 0.000 description 4
- 235000008584 Hovenia dulcis Nutrition 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 235000011187 glycerol Nutrition 0.000 description 4
- 210000004209 hair Anatomy 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000001681 protective effect Effects 0.000 description 4
- 235000002639 sodium chloride Nutrition 0.000 description 4
- 239000003826 tablet Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000009141 Houttuynia cordata plant extract Substances 0.000 description 3
- 235000008586 Hovenia Nutrition 0.000 description 3
- 241000405398 Hovenia Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000000440 bentonite Substances 0.000 description 3
- 229910000278 bentonite Inorganic materials 0.000 description 3
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000013376 functional food Nutrition 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000005445 natural material Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 241001573881 Corolla Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229940067866 dandelion extract Drugs 0.000 description 2
- 235000020691 dandelion extract Nutrition 0.000 description 2
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000007884 disintegrant Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000014509 gene expression Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 2
- 229930019673 naringin Natural products 0.000 description 2
- 229940052490 naringin Drugs 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000001845 taraxacum officinale leaf extract Substances 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 206010048909 Boredom Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001512 FEMA 4601 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- BCKXLBQYZLBQEK-KVVVOXFISA-M Sodium oleate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCC([O-])=O BCKXLBQYZLBQEK-KVVVOXFISA-M 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000006136 alcoholysis reaction Methods 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007975 buffered saline Substances 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000001120 cytoprotective effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000000741 diarrhetic effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 1
- 238000003028 enzyme activity measurement method Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 239000007986 glycine-NaOH buffer Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- ZGEGCLOFRBLKSE-UHFFFAOYSA-N methylene hexane Natural products CCCCCC=C ZGEGCLOFRBLKSE-UHFFFAOYSA-N 0.000 description 1
- WPHGSKGZRAQSGP-UHFFFAOYSA-N methylenecyclohexane Natural products C1CCCC2CC21 WPHGSKGZRAQSGP-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 235000019462 natural additive Nutrition 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229940027779 persimmon extract Drugs 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 235000019203 rebaudioside A Nutrition 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000004767 rumen Anatomy 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- RYYKJJJTJZKILX-UHFFFAOYSA-M sodium octadecanoate Chemical compound [Na+].CCCCCCCCCCCCCCCCCC([O-])=O RYYKJJJTJZKILX-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/334—Foods, ingredients or supplements having a functional effect on health treating the effects of consuming alcohol, narcotics or other addictive behavior, e.g. treating hangover or reducing blood alcohol levels
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Botany (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 곤달비 추출물을 포함하는 조성물 및 이를 이용한 숙취해소 음료의 제조에 관한 것으로, 보다 구체적으로 항산화 효과, 알코올 분해력 향상 효과 및 간 세포 보호 활성을 갖는 곤달비 (Ligularia stenocephala (Maxim.) Matsum. &Koidz.) 추출물 및 이를 이용한 숙취해소 음료의 제조에 관한 것이다.More particularly, the present invention relates to a composition containing an extract of Mandarb and a method of producing a hangover drink using the same, and more specifically, to a method for producing a Mandarin extract comprising Ligularia stenocephala (Maxim.) Matsum. & Koidz. ) Extract and a hangover-free beverage using the same.
간은 인간의 신체장기 중 생체 내 대사가 가장 활발하게 일어나는 장기로, 인체 내 소화기계와 전신순환계 사이에 위치하면서 외부에서 들어온 생체 외 물질로부터 전신을 방어하고, 수많은 종류의 영양소, 효소 및 생체 구성성분들을 생산하고 처리하는 기능을 수행하고 있어 인체의 화학공장으로도 비유된다. The liver is the most active organ in the body of the human body, which is located between the body's digestive system and the systemic circulatory system. It protects the body from exogenous substances coming in from the outside and contains a large number of nutrients, enzymes, It is also used as a chemical factory in the human body because it functions to produce and process components.
생체 내로 들어온 생체 외 물질은 간을 통과하게 되므로 간은 영양소 이외에도 많은 독성물질에 노출될 위험이 다른 장기보다 많아 그만큼 손상될 확률도 매우 높다. 또한, 간은 재생능력이 우수한 장기로 약간의 손상이 있을 경우에는 충분히 정상으로 회복되지만, 손상이 지속될 경우에는 간 조직의 일부가 완전히 파괴되고, 간 기능도 저하되는 등 정상 간으로의 회복이 어려운 상태가 된다.Since the in vivo substance entering the living body passes through the liver, the liver has a higher risk of being exposed to many toxic substances than the other organs in addition to the nutrients. In addition, the liver is regenerated to a normal state when there is a slight damage to organs having excellent regeneration ability, but when the damage is sustained, the liver is partially destroyed completely and the liver function is lowered, State.
간 손상은 정신적인 스트레스로 인해 초래되기도 하는데, 이 경우 정신적 휴식을 가져야 손상된 간세포가 복구되지만 현대사외에서 정신적 휴식의 여유를 찾기 어렵고 이에 더해 스트레스, 과음, 흡연으로 인한 손상의 가중으로 인해 인체가 방어 해독 작용을 하지 못해 다른 질병의 원인이 되기도 한다. Liver damage is caused by mental stress. In this case, the damaged hepatocytes need to be restored, but it is hard to find a room for resting spirit outside of modern history. In addition, due to stress, heavy drinking, It does not work and causes other diseases.
특히, 과음으로 인한 숙취는, 간세포에 축적된 알코올 및/ 또는 아세트 알데히드의 독성에 의해 발생하는 것으로, 알코올 및/ 또는 알데히드의 독성이 장시간 계속되면서 신진대사 등에 장애를 일으켜 전신 권태, 피로감, 복부팽만감, 구토 등의 증상을 일으키게 된다.Especially, a hangover due to overeating is caused by the toxicity of alcohol and / or acetaldehyde accumulated in the hepatocyte, and the toxicity of alcohol and / or aldehyde continues for a long time, causing a disorder of metabolism and the like and causing systemic boredom, fatigue, , And vomiting.
따라서 간질환에 영향을 미칠 수 있는 주요 원인을 해소하기 위해 알코올 분해 촉진효능이 있거나 황산화 효능이 있는 조성물에 대한 관심이 증가되고 있다.Therefore, there is an increasing interest in compositions that have the effect of promoting alcoholysis or having a sulfation effect in order to solve the main causes that may affect liver disease.
최근 들어, 다양한 간 보호용 기능성 물질 및 항산화 효과가 있는 물질에 대한 연구와 실험이 진행되고 있으며, 그 결과 의약품, 식품 및 화장품이 연구되고 판매되고 있으나, 합성된 화학물질과 같은 인체 부작용이 초래될 수 있는 소재를 사용하는 것들이 다수 있어, 천연식품이나 한약재료로부터 추출한 성분을 함유한 다양한 조성물의 개발이 필요하다.In recent years, researches and experiments have been carried out on various functional substances for liver protection and antioxidative effects, and as a result, medicines, foods and cosmetics have been studied and marketed, but such side effects as the synthesized chemicals may be caused There are a lot of things that use the materials that are available, and it is necessary to develop various compositions containing ingredients extracted from natural foods or herbal medicine materials.
이에 본 발명의 일 실시예에 따른 목적은 항산화 효과, 즉 활성산소 등 인체에 유해한 산화 물질에 대한 제거능이 높고, 간독성을 감소시키고 간 기능을 개선 시킬 수 있는 천연 소재인 곤달비 추출물 및 이를 유효성분으로 함유하는 숙취해소 음료를 제공하는 것이다.Accordingly, an object of the present invention is to provide an extract of Ganoderma lucidum, which is high in antioxidative effect, that is, a natural substance such as active oxygen, which has a high ability to remove oxidative substances that are harmful to human body, And to provide a hangover-eliminating beverage containing the same.
본 발명의 또다른 실시예에 따른 목적은 천연 소재인 곤달비 추출물 및 이를 유효성분으로 함유하는 항산화 효과, 즉 활성산소 등 인체에 유해한 산화 물질에 대한 제거능이 높은 화장품을 제공하는 것이다.Another object of the present invention is to provide a cosmetic which has a high extractability against gutral exudate of natural material and an antioxidative effect containing it as an active ingredient, that is, an oxidative substance harmful to human body such as active oxygen.
본 발명의 일 실시예에 따른 건강식품용 조성물은, 곤달비 추출물을 유효성분으로 함유한다.The composition for a health food according to an embodiment of the present invention contains a Ganoderma lucidum extract as an active ingredient.
상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물일 수 있다.The extract may be water, an organic solvent or a mixed solvent thereof.
상기 추출물은 조성물 총 중량에 대하여 1~90 중량%로 포함될 수 있다.The extract may be contained in an amount of 1 to 90% by weight based on the total weight of the composition.
상기 식품은 차류, 음료류, 육류, 초코렛, 식품류, 과자류, 피자, 라면, 기타 면류, 껌류, 사탕류, 아이스크림류, 알코올 음료류, 비타민 복합제 및 건강보조식품류로 중 하나일 수 있다.The food may be one of tea, beverage, meat, chocolate, food, confectionery, pizza, ramen, other noodles, gum, candy, ice cream, alcoholic beverage, vitamin complex and health supplement.
상기 조성물은 타크린(Tacrine) 또는 간손상을 유발하는 물질에 의한 간손상을 억제 또는 감소하는 활성을 갖을 수 있다.The composition may have activity to inhibit or reduce liver damage by tacrine or a substance that causes liver damage.
상기 조성물은 항산화 효능이 있을 수 있다.The composition may be antioxidant effective.
본 발명의 또 다른 실시예에 따른 화장품용 조성물은, 곤달비 추출물을 유효성분으로 함유한다.The composition for cosmetics according to another embodiment of the present invention contains a glutinous rice extract as an active ingredient.
상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물일 수 있다.The extract may be water, an organic solvent or a mixed solvent thereof.
상기 추출물은 조성물 총 중량에 대하여 1~90 중량%로 포함될 수 있다.The extract may be contained in an amount of 1 to 90% by weight based on the total weight of the composition.
상기 화장품은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이중 하나일 수 있다.The cosmetic may be a solution, a suspension, an emulsion, a paste, a gel, a cream, a lotion, a powder, an oil, a powder foundation, an emulsion foundation, a wax foundation and a spray.
상기 조성물은 항산화 효능이 있을 수 있다.The composition may be antioxidant effective.
또한, 본 발명은, 곤달비를 세척한 후, 수분을 제거하고 얇게 절단하는 단계, 절단된 상기 곤달비를 30~35℃의 온도에서 36~48시간 동안 건조시키는 단계, 건조된 상기 곤달비를 분쇄하는 단계, 분쇄된 상기 곤달비를 추출하여 추출물로 제조하는 단계 및 상기 추출물을 음료 첨가물들과 일정 비율로 혼합하여 음료를 제조하는 단계를 갖는 숙취해소 음료제조방법을 제공한다.In addition, the present invention relates to a method for removing moisture from a baguette, Drying the cut kondan briquettes at a temperature of 30 to 35 ° C for 36 to 48 hours, pulverizing the dried kondan briquettes, extracting the crushed gondolas to prepare an extract, and extracting the extracts with beverage additives And a step of mixing the beverage at a certain ratio to prepare a beverage.
본 발명은 곤달비 추출물을 유효성분으로 포함하는 화장품 또는 식품 조성물 및 이를 이용한 숙취해소 음료의 제조방법 에 관한 것으로, 곤달비 추출물을 이용하여 제조한 음료는 항산화 효과 및 간독성을 억제시키는 간기능 개선 효과가 있으며, 곤달비 추출물을 이용하여 제조한 화장품은 항산화 효과가 있어 유용하게 이용될 수 있다.The present invention relates to a cosmetic composition or a food composition containing an extract of Mandragon beryllium as an active ingredient and a method for producing a hangover resolved beverage using the same, wherein the beverage produced by using the Mandarin extract has an antioxidative effect and liver function improving effect for suppressing hepatotoxicity , Cosmetics manufactured by using the extract of Ganoderma lucidum can be usefully used because of its antioxidative effect.
도 1은 본 발명의 일실시예에 따른 곤달비 추출물을 포함하는 숙취해소 음료 제조방법에 대한 순서도를 나타낸 것이다.
도 2는 곤달비 추출물의 타크린 간손상 억제 측정 실험 결과를 나타낸 그래프이다.FIG. 1 is a flowchart illustrating a method for preparing a hangover solution containing the extract of Mandarin, according to an embodiment of the present invention.
FIG. 2 is a graph showing the experimental results of inhibition of tacrine liver damage by the extract of the Ganoderma Lucidum.
상술한 본 발명의 특징 및 효과는 첨부된 도면과 관련한 다음의 상세한 설명을 통하여 보다 분명해 질 것이며, 그에 따라 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 본 발명의 기술적 사상을 용이하게 실시할 수 있을 것이다. 본 발명은 다양한 변경을 가할 수 있고 여러 가지 형태를 가질 수 있는 바, 특정 실시예들을 도면에 예시하고 본문에 상세하게 설명하고자 한다. 그러나, 이는 본 발명을 특정한 개시 형태에 대해 한정하려는 것이 아니며, 본 발명의 사상 및 기술 범위에 포함되는 모든 변경, 균등물 내지 대체물을 포함하는 것으로 이해되어야 한다. 본 출원에서 사용한 용어는 단지 특정한 실시예들을 설명하기 위해 사용된 것으로, 본 발명을 한정하려는 의도가 아니다. 단수의 표현은 문맥상 명백하게 다르게 뜻하지 않는 한, 복수의 표현을 포함한다. 본 출원에서, "포함하다" 또는 "가지다" 등의 용어는 명세서에 기재된 특징, 숫자, 단계, 동작, 구성 요소, 부분품 또는 이들을 조합한 것이 존재함을 지정하려는 것이지, 하나 또는 그 이상의 다른 특징들이나 숫자, 단계, 동작, 구성 요소, 부분품 또는 이들을 조합한 것들의 존재 또는 부가 가능성을 미리 배제하지 않는 것으로 이해되어야 한다. 제1, 제2 등의 용어는 다양한 구성 요소들을 설명하는데 사용될 수 있지만, 상기 구성 요소들은 상기 용어들에 의해 한정되어서는 안 된다. 상기 용어들은 하나의 구성 요소를 다른 구성 요소로부터 구별하는 목적으로만 사용된다. 예를 들어, 본 발명의 권리 범위를 벗어나지 않으면서 제1 구성 요소는 제2 구성 요소로 명명될 수 있고, 유사하게 제2 구성 요소도 제1 구성 요소로 명명될 수 있다. BRIEF DESCRIPTION OF THE DRAWINGS The above and other features and advantages of the present invention will become more apparent from the following detailed description of the present invention when taken in conjunction with the accompanying drawings, It will be possible. The present invention is capable of various modifications and various forms, and specific embodiments are illustrated in the drawings and described in detail in the text. It should be understood, however, that the invention is not intended to be limited to the particular forms disclosed, but includes all modifications, equivalents, and alternatives falling within the spirit and scope of the invention. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. The singular expressions include plural expressions unless the context clearly dictates otherwise. In the present application, the terms " comprising " or " having ", and the like, are intended to specify the presence of stated features, integers, steps, operations, elements, parts, or combinations thereof, But do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, parts, or combinations thereof. The terms first, second, etc. may be used to describe various components, but the components should not be limited by the terms. The terms are used only for the purpose of distinguishing one component from another. For example, without departing from the scope of the present invention, the first component may be referred to as a second component, and similarly, the second component may also be referred to as a first component.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은, 곤달비 추출물을 유효 성분으로 함유하는 항산화 효과 및 간기능 개선 효과를 갖는 숙취해소용 음료를 제공한다.The present invention provides a small amount of hangover beverage having an antioxidative effect and liver function improving effect containing an extract of Ganoderma lucidum as an active ingredient.
본 발명의 재료로서, 상기 곤달비(Ligularia stenocephala (Maxim.) Matsum . & Koidz .)는 여러해 살이 풀로서 국내 여러 산간 지역에 자생한다. 근생엽은 꽃이 필 때까지 남아 있으며 심장형이고 끝이 갑자기 뵤족해지며 밑부분이 깊은 심장저이고 길이 24cm, 나비 20cm로서 표면에 털이 없으며 뒷면은 맥을 따라 털이 있고 가장자리에 뾰족한 톱니가 있으며, 엽병은 길이 40cm로서 날개가 없고 밑부분이 넓다. 줄기잎은 3개로서 밑부분의 것은 근생엽과 거의 같으며 긴 엽병의 밑부분이 원줄기를 감싸고 윗부분의 잎은 점차 작아지며 엽병도 짧아져서 엽초로 된다.As a material of the present invention, the above-mentioned Ligularia stenocephala (Maxim.) Matsum . & Koidz . ) Is a perennial plant that grows in many mountainous areas in Korea. The root-front leaf remains until flower is formed. It is heart-shaped, and the end is suddenly shortened. The lower part is deep deep, 24cm in length and 20cm long. There is no hairs on the surface. The back side has hairs along the vein. There are sharp sawtooth on the edge. It is 40cm long with no wings and broad base. The stem leaf is three, the bottom part is almost the same as the root lobe, the lower part of the long petiole envelopes the main stem, the upper leaf gradually becomes smaller, and the petiole becomes shorter.
꽃은 8-9월에 밑에서부터 위로 올라가면서 피고 지름 2-3cm이며 원줄기 끝의 총상꽃차례에 황색의 머리모양꽃차례가 달리고 꽃차례에 떨이 많으며 포는 길이 2-3mm로서 피침형이고 화경은 길이 1-3.5cm이다. 총포는 좁은 통형이며 길이 10-12mm, 나비 2.5-3mm이고 포편은 5개로서 뒤에 털이 약간 있으며 혀꽃은 1-3개이거나 간혹 없는 것도 있고 화관은 길이 20-25cm, 나비 3-4mm이며 판통은 길이 5-9mm이다.The flower grows from the bottom to the bottom in August-September. It has a diameter of 2-3cm. The head of the main stem has a yellowish-headed inflorescence on its tip, and the flower has many irises. The bract is 2-3mm long and lanceolate. 3.5 cm. It has a narrow tubular shape with a length of 10-12mm, a butterfly of 2.5-3mm, 5 pieces of hairs, and a few hairs on the back. There are 1-3 or sometimes no horseshoe. The corolla is 20-25cm long and the butterfly is 3-4mm. 5-9 mm.
수과는 길이 6-7mm로서 거꿀피침 모양이고 관모는 꽃부리보다 짧으며 갈백색이다.Achene is 6-7mm long and has a lanceolate lanceolate shape. Its tubular shape is shorter than the corolla and is white.
곤달비는 곰취와 같은 용도로 약용으로 쓰이며 민간에서는 부인병에 사용된다고 알려져 있다.It is said that it is used for medicinal purposes such as stinks and for gynecological diseases in the private sector.
본 발명자는 상기 식물 추출물이 항산화 효과를 가지고 있으며, 타크린(tacrine) 또는 간손상을 유발하는, 예를 들면, 알코올 등의 물질에 의한 간손상을 억제시켜, 간 세포를 보호하는 효과가 있음을 규명하였다.The present inventors have found that the above plant extract has an antioxidative effect and has an effect of inhibiting liver damage caused by, for example, alcohol or the like, which causes tacrine or liver damage, thereby protecting liver cells Respectively.
이하, 본 발명에 따른 곤달비 추출물을 제조하는 방법을 상세히 설명한다.Hereinafter, a method for preparing the extract of the present invention will be described in detail.
본 발명에 따른 곤달비 추출물은 천연으로부터 추출 및 분리하여 수득한 것을 사용할 수 있으며, 본 발명에서 정의된 추출물은 적절한 용매를 이용하여 곤달비로부터 추출한 것이다. 예를 들어, 곤달비 식물의 조추출물, 극성용매 가용 추출물 또는 비극성용매 가용 추출물을 모두 포함한다.The extracts of the present invention can be obtained by extracting and isolating the extracts from natural sources, and the extracts of the present invention are extracted from the extracts of gondolas using an appropriate solvent. For example, it includes all of crude extracts, polar solvent-soluble extracts, and non-polar solvent-soluble extracts of a mildew plant.
바람직하게는 곤달비 식물의 잎, 꽃, 줄기, 뿌리에서 추출한 추출물일 수 있다.Preferably, it may be an extract extracted from leaves, flowers, stems, and roots of a mussel plant.
상기 곤달비 추출물을 추출하기 적절한 용매로는 약학적으로 허용되는 유기용매라면 어느 것을 사용해도 무방하며, 물 또는 유기용매를 사용할 수 있으며, 이에 제한되지는 않으나, 예를 들어, 정제수, 메탄올(methanol), 에탄올(ethanol), 프로판올(propanol), 이소프로판올(isopropanol), 부탄올(butanol) 등을 포함하는 탄소수 1 내지 4의 알코올, 아세톤(acetone), 에테르(ether), 벤젠(benzene), 클로로포름(chloroform), 에틸아세테이트(ethyl acetate), 메틸렌클로라이드(methylene chloride), 헥산(hexane) 및 시클로헥산(cyclohexane) 등의 각종 용매를 단독으로 혹은 혼합하여 사용할 수 있다.Examples of suitable solvents for extracting the above-mentioned extracts include water, organic solvents and the like, and may be, for example, purified water, methanol, Alcohol having 1 to 4 carbon atoms, acetone, ether, benzene, chloroform, and the like, including water, ethanol, propanol, isopropanol, butanol, Various solvents such as ethyl acetate, methylene chloride, hexane and cyclohexane may be used alone or in combination.
추출 방법으로는 열수추출법, 냉침추출법, 환류냉각추출법, 용매추출법, 수증기증류법, 초음파추출법, 용출법, 압착법 등의 방법 중 어느 하나를 선택하여 사용할 수 있다. 또한, 목적하는 추출물은 추가로 통상의 분획 공정을 수행할 수도 있으며, 통상의 정제 방법을 이용하여 정제될 수도 있다.As the extraction method, any one of the methods such as hot water extraction method, cold extraction method, reflux cooling extraction method, solvent extraction method, steam distillation method, ultrasonic extraction method, elution method and compression method can be selected and used. In addition, the desired extract may be further subjected to a conventional fractionation process or may be purified using a conventional purification method.
본 추출물의 제조방법에는 제한이 없으며, 공지되어 있는 어떠한 방법도 이용될 수 있다.There is no limitation on the production method of the extract, and any known method can be used.
예를 들면, 상기 곤달비 추출물은 상기한 열수 추출 또는 용매 추출법으로 추출된 1차 추출물을, 감압 증류 및 동결 건조 또는 분무 건조 등과 같은 추가적인 과정에 의해 분말 상태로 제조할 수 있다. 또한 상기 1차 추출물을 실리카겔 컬럼 크로마토그래피(silica gel column chromatography), 박층 크로마토그래피(thin layer chromatography), 고성능 액체 크로마토그래피(high performance liquid chromatography) 등과 같은 다양한 크로마토그래피를 이용하여 추가로 정제된 분획을 얻을 수도 있다.For example, the above-mentioned first extract of the Ganoderma extract can be prepared in powder form by an additional process such as vacuum distillation, freeze-drying or spray drying. Further, the primary extract can be further purified by using various chromatographies such as silica gel column chromatography, thin layer chromatography, high performance liquid chromatography and the like, You can get it.
따라서 본 발명에 있어서 곤달비 추출물은 추출, 분획 또는 정제의 각 단계에서 얻어지는 모든 추출액, 분획 및 정제물, 그들의 희석액, 농축액 또는 건조물을 모두 포함하는 개념이다.Therefore, in the present invention, the Gundalb extract is a concept including all the extracts, fractions, and purified products obtained in each step of extraction, fractionation or purification, their diluted solutions, concentrates or dried products.
추출된 상기 곤달비 추출물을 이용하여 본 발명의 일 실시예인 숙취해소 음료를 제조할 수 있는 조성물을 제조할 수 있다.A composition capable of producing a hangover-resolved beverage, which is one embodiment of the present invention, can be prepared using the extracted Ganoderma extract.
본 발명의 일 실시예에 있어서, 본발명의 곤달비 추출물은 상기 조성물에 10 내지 100000ppm의 농도로 포함될 수 있으며, 또한 본 발명의 상기 추출물은 조성물 총중량에 대하여 1~90중량%로 포함될 수 있다.In one embodiment of the present invention, the dandelion extract of the present invention may be contained in the composition at a concentration of 10 to 100000 ppm, and the extract of the present invention may be contained in an amount of 1 to 90% by weight based on the total weight of the composition.
상기 조성물은 상기 추출물을 유효성분으로 함유하는 식품 조성물일 수 있는데, 이러한 식품 조성물은 유효성분인 상기 곤달비 추출물을 함유하는 것 외에 통상의 식품 조성물과 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.The composition may be a food composition containing the extract as an active ingredient. In addition to containing the active ingredient of the above-mentioned extract, the food composition may contain various flavors or natural carbohydrates as an additional ingredient ≪ / RTI >
상기 천연 탄수화물은, 예를 들어, 모노사카라이드, 예를 들어, 포도당, 과당 등;디사카라이드, 예를 들어 말토스,슈크로스 등; 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 상술한 향미제는 천연 향미제 (타우마틴), 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제 (사카린, 아스파르탐 등)를 유리하게 사용할 수 있다.Such natural carbohydrates include, for example, monosaccharides such as glucose, fructose, etc .; disaccharides such as maltose, sucrose, etc .; And polysaccharides, for example, conventional sugars such as dextrin, cyclodextrin and the like, and sugar alcohols such as xylitol, sorbitol and erythritol. The above-described flavors can be advantageously used as natural flavorings (tau martin), stevia extracts (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.).
또한, 본 발명의 식품 조성물은 상기 기재한 유효성분 이외에 추가로 식품학적으로 허용 가능하거나 약제학적으로 허용 가능한 담체를 1종 이상 포함하여 식품 조성물로 바람직하게 제제화할 수 있다.In addition, the food composition of the present invention may be formulated into a food composition in addition to the above-described effective ingredients, including at least one pharmaceutically acceptable or pharmaceutically acceptable carrier.
상기 식품 조성물의 제제 형태는 정제, 캡슐제, 분말, 과립, 액상, 환, 액제, 시럽, 즙, 현탁제, 유제, 또는 점적제 등이 될 수 있다. 예를 들어, 정제 또는 캡슐제의 형태로의 제제화를 위해, 유효 성분은 에탄올, 글리세롤, 물 등과 같은 경구, 무독성의 약제학적으로 허용 가능한 불활성 담체와 결합될 수 있다. 또한, 원하거나 필요한 경우, 적합한 결합제, 윤활제, 붕해제 및 발색제 또한 혼합물로 포함될 수 있다. 적합한 결합제는 이에 제한되는 것은 아니나, 녹말, 젤라틴, 글루코스 또는 베타-락토오스와 같은 천연 당, 옥수수 감미제, 아카시아, 트래커캔스 또는 소듐올레이트와 같은 천연 및 합성 검, 소듐 스테아레이트, 마그네슘 스테아레이트, 소듐 벤조에이트, 소듐 아세테이트, 소듐 클로라이드 등을 포함한다. 붕해제는 이에 제한되는 것은 아니나, 녹말,메틸 셀룰로스, 아가, 벤토니트, 잔탄 검등을 포함한다. 액상 용액으로 제제화되는 조성물에 있어서 허용 가능한 약제학적 담체로는, 멸균 및 생체에 적합한 것으로서, 식염수, 멸균수, 링거액, 완충 식염수, 알부민 주사용액, 덱스트로즈 용액, 말토 덱스트린 용액, 글리세롤, 에탄올 및 이들 성분 중 1 성분 이상을 혼합하여 사용할수 있으며, 필요에 따라 항산화제, 완충액, 정균제 등 다른 통상의 첨가제를 첨가할 수 있다. 또한 희석제, 분산제, 계면활성제, 결합제 및 윤활제를 부가적으로 첨가하여 수용액, 현탁액, 유탁액 등 과 같은 주사용 제형, 환약, 캡슐, 과립 또는 정제로 제제화할 수 있다.The form of the food composition may be a tablet, a capsule, a powder, a granule, a liquid, a ring, a liquid, a syrup, a juice, a suspension, an oil, or a drip agent. For example, for formulation into tablets or capsules, the active ingredient may be combined with an oral, non-toxic pharmaceutically acceptable inert carrier such as ethanol, glycerol, water, and the like. Also, if desired or necessary, suitable binders, lubricants, disintegrants and coloring agents may also be included as a mixture. Suitable binders include, but are not limited to, natural sugars such as starch, gelatin, glucose or beta-lactose, natural and synthetic gums such as corn sweeteners, acacia, tracker candles or sodium oleate, sodium stearate, magnesium stearate, sodium Benzoate, sodium acetate, sodium chloride, and the like. Disintegrants include, but are not limited to, starch, methylcellulose, agar, bentonite, xanthan gum, and the like. Acceptable pharmaceutical carriers for compositions that are formulated into a liquid solution include sterile water and sterile water suitable for the living body such as saline, sterile water, Ringer's solution, buffered saline, albumin injection solution, dextrose solution, maltodextrin solution, glycerol, One or more of these components may be mixed and used. If necessary, other conventional additives such as an antioxidant, a buffer, and a bacteriostatic agent may be added. In addition, diluents, dispersants, surfactants, binders, and lubricants can be additionally added to formulated into injectable solutions, pills, capsules, granules or tablets such as aqueous solutions, suspensions, emulsions and the like.
상기와 같은 방식으로 제제화된 본 발명의 식품 조성물은 기능석 식품으로 이용하거나, 각종 식품에 첨가될 수 있다.The food composition of the present invention formulated in the above-described manner can be used as a functional food or can be added to various foods.
발명의 조성물을 첨가할 수 있는 식품으로는 예를 들어, 차류, 음료류, 육류, 초코렛, 식품류, 과자류, 피자, 라면, 기타 면류, 껌류, 사탕류, 아이스크림류, 알코올 음료류, 비타민 복합제 및 건강보조식품류 등이 있다.Foods to which the composition of the present invention can be added include, for example, foods such as tea, beverage, meat, chocolate, food, confectionery, pizza, ramen, other noodles, gums, candy, ice cream, alcoholic beverages, .
또한 상기 식품 조성물은 유효성분인 곤달비 추출물 외에 여러 가지 영양제, 비타민, 광물 (전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제 (치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그밖에 본 발명의 식품 조성물은 천연 과일 쥬스 및 과일 쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다.In addition, the food composition may contain various additives such as nutrients, vitamins, minerals (electrolytes), synthetic flavors and flavors such as natural flavors, coloring agents and aging agents (such as cheese and chocolate), pectic acid and its salts , Alginic acid and its salts, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks and the like. In addition, the food composition of the present invention may contain natural fruit juice and pulp for the production of fruit juice drinks and vegetable drinks.
본 발명의 유효성분인 곤달비 추출물은 천연물질로서 화학약품과 같은 부작용은 거의 없으므로 항산화 효과, 알코올 분해력 증진 효과, 간세포 보호 효과를 목적으로 장기간 복용시에도 안심하고 사용할 수 있다.The active ingredient of the present invention is a natural substance, which has almost no side effects such as chemical agents. Therefore, it can be safely used for long-term administration for the purpose of antioxidative effect, alcohol decomposing ability improving effect and hepatocyte protective effect.
따라서, 본 발명은 곤달비 추출물을 유효성분으로 포함하는 간기능 개선을 위한 건강식품을 제공한다.Accordingly, the present invention provides a health food for improving liver function, comprising the extract of Mandarin, as an active ingredient.
본 발명의 건강기능식품은 항산화 효과, 알코올 분해력 증진 효과, 간세포 보호 효과 등과 같은 간기능 개선을 목적으로, 정제, 캅셀, 분말, 과립, 액상, 환 등의 형태로 제조 및 가공할 수 있다. The health functional food of the present invention can be manufactured and processed in the form of tablets, capsules, powders, granules, liquids, and circles for the purpose of improving liver function such as antioxidative effect, alcohol decomposability improving effect, hepatocyte protective effect and the like.
본 발명의 건강기능식품은 통상의 식품 첨가물을 포함할 수 있으며, 식품 첨가물로서의 적합 여부는 다른 규정이 없는 한, 식품의약품안전청에 승인된 식품 첨가물 공전의 총칙 및 일반시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다.The health functional foods of the present invention may contain conventional food additives and, unless otherwise specified, whether or not they are suitable as food additives are classified according to the General Rules for Food Additives approved by the Food and Drug Administration, Standards and standards.
상기 식품 첨가물 공전에 수재된 품목으로는 예를 들어, 케톤류, 글리신, 구연산칼슘, 니코틴산, 계피산 등의 화학적 합성물; 감색소, 감초추출물, 결정 셀룰로오스, 고량색소, 구아검 등의 천연첨가물; L-글루타민산나트륨 제제, 면류첨가알칼리제, 보존료제제, 타르색소제제 등의 혼합제제류 등을 들 수 있다.Examples of the food items included in the above food additives include chemical compounds such as ketones, glycine, calcium citrate, nicotinic acid, and cinnamic acid; Natural additives such as persimmon extract, licorice extract, crystalline cellulose, high color pigment and guar gum; L-glutamic acid sodium preparations, noodle-added alkalis, preservative preparations, tar coloring preparations and the like.
또한, 본 발명의 곤달비 추출물은 수분크림, 영양 크림 등과 같은 화장품 소재로 사용할 수 있다.Further, the dandelion extract of the present invention can be used as a cosmetic material such as a water cream, a nutritional cream, and the like.
본 발명의 화장품 조성물은 유효성분인 곤달비 추출물 외에 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제, 그리고 담체를 포함할 수 있다.The cosmetic composition of the present invention may contain conventional additives such as stabilizers, solubilizers, vitamins, pigments and flavoring agents, and carriers in addition to the active ingredient, Ganoderma extract.
상기 화장료 조성물은 항산화 효과를 목적으로, 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있으며, 예를 들어, 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이 등으로 제형화될 수 있으나, 이에 한정되는 것은 아니다. 보다 상세하게는, 썬 크림, 유연 화장수, 수렴 화장수, 영양 화장수, 영양 크림, 마사지 크림, 에센스, 아이 크림, 팩, 스프레이 또는 파우더의 제형으로 제조될 수 있다.For the purpose of antioxidant effect, the cosmetic composition may be prepared in any form conventionally produced in the art, and examples thereof include solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, oils, powders A foundation, an emulsion foundation, a wax foundation and a spray, but the present invention is not limited thereto. More specifically, it can be manufactured in the form of a sun cream, a flexible lotion, a convergent lotion, a nutritional lotion, a nutritional cream, a massage cream, an essence, an eye cream, a pack, a spray or a powder.
상기 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물성유, 식물성유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation is a paste, cream or gel, an animal oil, a vegetable oil, a wax, a paraffin, a starch, a tracer, a cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component .
상기 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In the case of a spray, in particular, chlorofluorohydrocarbons, propane / Or propellants such as dimethyl ether.
상기 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해 화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation is a solution or an emulsion, a solvent, a solubilizing agent or an emulsifying agent is used as a carrier component, and examples thereof include water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, - butyl glycol oil, glycerol aliphatic ester, polyethylene glycol or fatty acid esters of sorbitan.
상기 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상의 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation is a suspension, a carrier such as water, a liquid diluent such as ethanol or propylene glycol, a suspension such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, a microcrystalline cellulose , Aluminum metahydroxide, bentonite, agar or tracant, etc. may be used.
본 발명의 일 실시예에 따른 숙취해소 음료 제조방법을 도면을 참조하여 더욱 상세하게 설명하도록 한다.A method of manufacturing a hangover-free beverage according to an embodiment of the present invention will be described in detail with reference to the drawings.
<실시예><Examples>
도 1을 참조하면, 본 발명의 일 실시예에 따른 숙취해소 음료 제조방법은, 먼저 곤달비를 세척한 후, 수분을 제거하고 얇게 절단한다(S10). 이후 30~35℃의 온도에서 36~48시간 동안 건조시키고(S20), 건조된 재료들을 분쇄시킨다(S30). 분쇄된 상기 곤달비를 추출하여 곤달비 추출물로 제조(S40)하여 상기 추출물을 음료 첨가물들과 일정 비율로 혼합하여 음료를 제조(S50)하는 것으로 상기 숙취해소 음료 제조방법은 종결된다. Referring to FIG. 1, in a method of manufacturing a hangover-solving beverage according to an embodiment of the present invention, water is removed and sliced (S10). Thereafter, it is dried at a temperature of 30 to 35 DEG C for 36 to 48 hours (S20), and the dried materials are pulverized (S30). The method of manufacturing a hangover-free beverage according to the present invention comprises the steps of: (a) preparing a bean curd refuse; (b) preparing a bean curd refuse;
분쇄된 상기 곤달비를 추출하여 추출물로 제조하는 여러방법은, 곤달비 추출물 제조방법에서 추출물로 제조하는 제조방법들을 사용하는 것과 동일하므로, 이에 대한 상세한 설명은 생략한다.The various methods of extracting the above-mentioned crushed gangbang extracts and producing them as the extracts are the same as those using the production methods of extracts in the method of producing the Kangaroobi extract, and a detailed description thereof will be omitted.
본 발명의 일 실시예에 따른 곤달비의 효능을 확인하기 위한 실험 및 그에 따른 결과를 더욱 상세하게 설명하도록 한다.Experiments for confirming the efficacy of the dumplings according to an embodiment of the present invention and the results thereof will be described in more detail.
본 발명의 곤달비 효능을 확인하기 위하여 제조된 숙취해소 음료에 사용된 곤달비 추출물을 추출하기 위한 추출법으로는 식용으로 적합한 열수 추출과 유효성분을 대부분 추출할 수 있는 70% 에탄올 수용액을 이용하는 추출법 두 가지 방법을 이용하였으며, 70% 에탄올 수용약의 경우 다시 극성에 따라 헥산, 클로로포름, 에틸아세테이트 그리고 물 층으로 분획해 실험하였다.As an extraction method for extracting the dung beetle extract used in the hangover-free beverage manufactured to confirm the dungbean efficacy of the present invention, there are two methods of extracting hot water suitable for edible use and a 70% ethanol aqueous solution capable of extracting most active ingredients And 70% ethanol solution was fractionated into hexane, chloroform, ethyl acetate and water according to polarity.
<실험 예 1><Experimental Example 1>
본 발명에 있어 곤달비 추출물의 폴리페놀, 플라보노이드 등과 같은 항산화 물질의 함량과 항산화 효과측정, 알코올 분해력 증진 및 세포 보호 효과 측정은 간 독성 해소 및 숙취 해소 활성을 갖는 물질을 포함하는 헛개나무의 열매 및 줄기 추출물과 동일한 조건에서 비교하며 수행하였다.In the present invention, the content and antioxidative effect of antioxidative substances such as polyphenols, flavonoids and the like of the extract of the Ganoderma lucidum extract are measured, the alcohol decomposition ability is enhanced and the cytoprotective effect is measured. The fruit and stem of the hinoki tree containing the substance having hepatic toxicity resolution and hangover resolution activity The extracts were compared under the same conditions.
<1-1>총 폴리페놀 함량 측정<1-1> Total polyphenol content measurement
폴리페놀(polyphenol)에 포함되는 페놀성 수산기는 활성산소를 제거하는 기능이 있기 대문에 폴리페놀은 항산화 작용을 가진 성분이라고 할 수 있다.The phenolic hydroxyl group contained in polyphenol has a function of removing active oxygen, so polyphenol is an antioxidant component.
총 폴리페놀 함량은 Velioglu et al. (1998)의 방법으로 측정하였으며, 추출물 0.2ml, 2% 탄산나트륨(Na2CO3) 4ml를 혼합하고 3분 후에 1N Folin-Ciocalteu (F-C) 시약 (F9252, Sial, USA)을 0.2 ml 첨가하여 실온에서 30분 동안 반응 시킨 후 자외선 가시광선 분광광도계 (Cary 4000, Varian)로 750 nm에서 흡광도를 측정하였다.Total polyphenol content was determined by Velioglu et al . (1998) method was measured by the extract 0.2ml, 2% sodium carbonate (Na 2 CO 3) were mixed and added to 4ml 1N Folin-Ciocalteu (FC) reagent (F9252, Sial, USA) After three minutes at room temperature 0.2 ml (Cary 4000, Varian). The absorbance at 750 nm was measured by ultraviolet ray visible spectrophotometer (Cary 4000, Varian).
위 표 1은 헛개 추출물과 곤달비 추출물의 총 폴리페놀 함량 시험 결과를 나타낸 표이다. 상기 표 1에서 나타난 바와 같이 곤달비 추출물의 총 폴리페놀 함량이 헛개에 비해 높은 것을 확인할 수 있다. Table 1 shows the results of the total polyphenol content of Hovenia dulcifera and Ganoderma extract. As shown in Table 1, it can be seen that the total polyphenol content of the extracts of the Ganoderma lucidum extract is higher than that of the hovenae extracts.
<1-2>총 플라보노이드 함량 측정<1-2> Measurement of total flavonoid content
플라보노이드는 항알레르기, 항염증, 항산화 물질, 항미생물, 암 설사 방지 활성 등의 효과를 가지고 있다. Flavonoids have antiallergic, anti-inflammatory, antioxidant, antimicrobial and anti-cancer diarrheal activity.
총 플라보노이드 함량은 NFRI (1990)의 방법으로 측정하였으며, 추출물 0.4 ml, 디메틸글리콜(dimethyl glycol)(111-46-6, Jun, Japan) 4 ml, 1N NaOH 0.4 ml을 첨가하여 37℃의 진탕항온수조에서 1시간 반응시킨 후 420 nm에서 흡광도를 측정하였다. 나린긴(Naringin) (N0073, TCI, Japan)을 표준물질로 하여 작성한 검량선을 이용하여 건조시료 g당 총 플라보노이드 함량 (mg·- 1)을 naringin 기준으로 환산하여 나타냈다.Total flavonoid content was measured by NFRI (1990) method. 0.4 ml of the extract, 4 ml of dimethyl glycol (111-46-6, Jun, Japan) and 0.4 ml of 1N NaOH were added and incubated at 37 ° C After reacting for 1 hour in a water bath, absorbance was measured at 420 nm. The total flavonoid content (mg · - 1 ) per g of dry sample was converted to the naringin standard using a calibration curve prepared using Naringin (N0073, TCI, Japan) as a reference material.
위 표 2는 헛개 추출물과 곤달비 추출물의 총 플라보노이드 함량 시험 결과이다. 표 2에서 나타난 바와 같이 곤달비 추출물의 총 플라보노이드 함량이 헛개에 비해 높은 것을 확인할 수 있다.Table 2 shows the results of total flavonoid content test for the Houttuynia cordata extract and the Kundalini extract. As shown in Table 2, it can be confirmed that the total flavonoid content of the extracts of the Ganoderma lucidum extract is higher than that of the hovenae.
<1-3> 항산화 효과 및 간기능 보호 효과 측정<1-3> Measurement of antioxidative and hepatic function protection
본 발명의 일 실시예에 따른 상기 곤달비 추출물의 항산화 효과 측정은 DPPH 라디칼 소거활성, ABTS 라디칼 소거활성법을 사용해 확인 하였고, 간 기능 보효 효과는 ADH 효소 활성 측정, HepG2 간세포와 tacrine을 이용한 간세포 보호 효과를 측정하는 방법이 있으며, 본 발명에서는 헛개 추출물과 곤달비 추출물의 활성을 각각 측정하여 비교하였다.The antioxidative effect of the extract of the present invention was confirmed by the DPPH radical scavenging activity and the ABTS radical scavenging activity method. The hepatic function coagulation effect was measured by ADH enzyme activity assay, hepatocyte protective effect using HepG2 hepatocyte and tacrine . In the present invention, the activities of the Houttuynia cordata extract and the Gondwabi extract were respectively measured and compared.
<1-3-1> DPPH 라디칼 소거 활성<1-3-1> DPPH radical scavenging activity
농도별 추출물 1 ml와 0.15 mM DPPH (1,1-diphenyl-2-picrylhydrazyl; D9132, Aldrich, USA) (Molyneux, 2004) 용액 4 ml을 혼합하여 실온·암 상태에서 30분 동안 반응시킨 후 517 nm에서 흡광도를 측정하였다 (Blois, 1958). 전자공여능 (EDA)은 시료 첨가구와 시료 무첨가구의 흡광도 차이를 아래의 계산식(1)에 의하여 백분율 (%)로 구하였으며, 단순회귀분석을 통하여 시료 무첨가구의 EDA를 50% 감소시키는데 필요한 시료의 농도 (mg·-1)를 RC50값으로 나타냈다. 양성 대조군으로는 L-아스코르브산(50817, Aldrich, USA)을 사용 하였다.1 ml of each concentration extract and 4 ml of 0.15 mM DPPH (1,1-diphenyl-2-picrylhydrazyl; D9132, Aldrich, USA) (Molyneux, 2004) were mixed and reacted for 30 minutes at room temperature and darkness. (Blois, 1958). (EDA) was calculated by the following equation (1) as the percentage of absorbance difference between sample addition and no sample addition. The simple regression analysis showed that the concentration of the sample required to reduce EDA by 50% mg · -1 ) was expressed as RC 50 value. As a positive control, L-ascorbic acid (50817, Aldrich, USA) was used.
전자공여능(EDA,%) = [(control-sample) / control ] ×100 계산식(1)Electron donating ability (EDA,%) = [(control-sample) / control] × 100 Equation (1)
위의 표 3은 헛개 추출물과 곤달비 추출물의 DPPH 라디칼 소거능 측정 시험 결과를 나타낸 표이다.Table 3 above shows the results of DPPH radical scavenging test of Hovenia dulcifera and Ganoderma lucidum extract.
헛개 추출물과 곤달비 추출물의 DPPH 라디칼 소거능 측정결과 열수 곤달비는 800 ppm 부터 24.98%의 전자공여능이 나타났고, 열수 헛개의 경우에는 1,000 ppm 부터 13.58%의 전자공여능을 내는 것으로 확인되었다. 기타의 경우에도 일반적으로 곤달비 추출물이 헛개 추출물 보다 전자공여능이 우수한 것으로 확인 되었다.DPPH radical scavenging activity of Hovenia dulcis extracts and Ganoderma lucidum extracts was found to be electron donating ability from 800 ppm to 24.98% and from 1,000 ppm to 13.58% in hydrothermal solution. In other cases, it was found that the extract of Ganoderma lucidum generally had better electron donating ability than that of the hound extract.
<1-3-2> ABTS 라디칼 소거 활성<1-3-2> ABTS radical scavenging activity
ABTS 라디칼 총 항산화력 측정법은 수용성, 지용성 항산화제 모두 적용이 가능하고 실험법이 비교적 간단하며 감도가 좋은 장점을 이용해 (Pellegrini et al., 1999) 7.4 mM의 ABTS와 2.6 mM 과황화칼륨(potassium persulfate)를 혼합하여 실온·암소에서 24시간 동안 방치하여 라디칼을 형성시켰다. ABTS용액은 실험 직전에 732 nm에서 흡광도가 0.70(mean±이 되도록 PBS (pH 7.4)로 희석하여 사용하였다. 농도별 추출물 50 ㎕에 ABTS 용액 950 ㎕를 첨가하여 암소에서 10분간 반응시킨 후 732 nm에서 흡광도를 측정하였다 (Blois, 1958; Osman et al., 2006). ABTS 라디칼 소거능 (RC50)은 DPPH 라디칼 소거능과 같은 방법으로 구하였으며, 대조군의 흡광도를 50% 감소시키는데 필요한 가용성 고형분의 농도 (mg·-1)로 나타냈다. 라디칼 소거능을 비교하기 위한 양성 대조군은 L-아스코르브산을 사용하였다.The total antioxidant activity of ABTS radicals was measured by using 7.4 mM ABTS and 2.6 mM potassium persulfate, using both water-soluble and lipid-soluble antioxidants. The method was relatively simple and sensitive (Pellegrini et al ., 1999) Were mixed and allowed to stand at room temperature and in a dark place for 24 hours to form radicals. The ABTS solution was diluted with PBS (pH 7.4) to an absorbance of 0.70 (mean ± 732 nm) at 732 nm, and 950 μl of ABTS solution was added to 50 μl of the extract by concentration. absorbance was measured at. (Blois, 1958;. Osman et al, 2006) ABTS radical scavenging activity (RC 50) was obtain in the same way as the DPPH radical scavenging activity, the concentration of the soluble solid required to reduce the absorbance of the control group and 50% ( mg · -1 ). L-ascorbic acid was used as a positive control to compare the radical scavenging ability.
위의 표 4는 헛개 추출물과 곤달비 추출물의 ABTS 라디칼소거 활성 측정 시험 결과를 나타낸 표이다.Table 4 shows the results of the ABTS radical scavenging activity test of the hound extract and the rumen extract.
헛개 추출물과 곤달비 추출물의 ABTS 라디칼소거 효소 활성 측정 시험 결과 열수 곤달비는 200 ppm 부터 17%의 활성이 나타났고, 열수 헛개의 경우에는 300 ppm 에서 5%의 활성을 열수 곤달비는 26%의 활성을 보이는 것으로 확인되었다. 기타의 경우에도 일반적으로 곤달비 추출물이 헛개 추출물 보다 활성이 우수한 것으로 확인 되었다. The results of the ABTS radical scavenging activity test of the extracts of Hovenia dulcifera and Gondorvii showed that the hydrothermal activity increased from 200 ppm to 17%, the hydrothermal activity increased to 5% at 300 ppm and the activity of hydrothermal activity was 26% Respectively. In other cases, it was generally found that the extract of Ganoderma lucidum was superior to the extract of Hovenia dulcis.
<1-3-2>알코올 탈수소효소 (alcohol dehydrogenase, ADH) 활성 측정<1-3-2> Measurement of alcohol dehydrogenase (ADH) activity
ADH 효소 활성 측정은 Choi 등과 Racker의 방법을 변형하여 수행하였으며, 생성된 NADH의 양을 340 nm에서 흡광도를 측정하였다. 시험관에 alcohol 0.1 mL, NAD 수용액(2 mg/mL) 0.5 mL 및 시료 0.1 mL를 첨가하고 10 mM 글리신 수산화나트륨 버퍼(glycine-NaOH buffer)(pH 8.8)를 총 부피가 1.8 mL가 되게 조절한 후 25°항온수조에서 10분간 반응시키고, ADH(10 unit/mL)를 가하여 340 nm에서 흡광도의 변화를 측정하였다.The ADH enzyme activity was measured by the modified method of Choi et al. And Racker. The absorbance of the produced NADH was measured at 340 nm. Add 0.1 mL of alcohol, 0.5 mL of NAD aqueous solution (2 mg / mL) and 0.1 mL of the sample to the test tube, and adjust the volume to 1.8 mL with 10 mM glycine-NaOH buffer (pH 8.8) The reaction was carried out for 10 minutes in a 25 ° constant-temperature water bath, and the change in absorbance at 340 nm was measured by adding ADH (10 unit / mL).
위의 표 5는 헛개 추출물과 곤달비 추출물의 ADH 효소 활성 측정 시험 결과를 나타낸 표이다.Table 5 above shows the test results of the ADH enzyme activity measurement of the Houttuynia cordata extract and the Gondweed extract.
헛개 추출물과 곤달비 추출물의 ADH 효소 활성 측정 시험 결과 열수 곤달비는 80 ppm 에서 400%의 활성이 나타났고, 열수 헛개의 경우에는 80 ppm 에서 154%의 활성을 보이는 것으로 확인되었다. 기타의 경우에도 일반적으로 곤달비 추출물이 헛개 추출물 보다 활성이 우수한 것으로 확인 되었다. The ADH enzyme activities of the extracts of Hovenia dulcis and Ganoderma lucidum were determined to be 400% at 80 ppm and 154% at 80 ppm in hydrothermal solution. In other cases, it was generally found that the extract of Ganoderma lucidum was superior to the extract of Hovenia dulcis.
<실험 예 2><Experimental Example 2>
본 발명의 일실시예에 따른 곤달비 추출물을 이용하여, 간세포를 손상시키는 타크린(tacrine)물질에 의한 간세포 손상이 억제되는 지에 대한 실험을 진행하였다. Experiments were conducted to determine whether inhibition of hepatocyte damage by tacrine substances damaging hepatocytes was induced by using the extract of Ganoderma lucidum according to one embodiment of the present invention.
실험에 이용된 간세포는, 10% 비동화소태아혈청(heat-inactivated fetal bovine serum) 및 100 U/mL 페니실린(penicillin)과 100 μg/mL 스트렙토마이신(streptomycin)이 첨가된 MEM 배지를 이용하여 37 ℃, 5% CO2인큐베이터에서 에서 배양한 간세포 Hep G2를 사용하였다.The hepatocytes used in the experiments were cultured in MEM medium supplemented with 10% heat-inactivated fetal bovine serum and 100 U / mL penicillin and 100 μg / mL streptomycin at 37 ° C. , Hepatocyte Hep G2 cultured in a 5% CO 2 incubator was used.
실험방법은, 간세포만 있는 컨트롤군(C), 간세포와 타크린이 배양된 타크린군(Tacrine)을 비교군으로 하고, 간세포와 타크린이 배양된 셀에 곤달비 추출물을 각각 10 μg/mL, 50 μg/mL, 100 μg/mL, 200 μg/mL을 0.15 mM 농도로 투여하여 24시간 및 48시간 배양하였다.The experimental groups were as follows: control group (C) containing only hepatocytes, tacrine group (Tacrine) cultured with hepatocytes and tacrine, and 10 μg / mL of each group of hepatocytes and tacrine- 50 μg / mL, 100 μg / mL, and 200 μg / mL were incubated at the concentration of 0.15 mM for 24 hours and 48 hours.
다시, 상기 MEM 배지를 제거한 후 MTT 시약 100 μL (5mg/mL in PBS) 넣고 37 ℃ 이산화탄소분위기에서 에서 2-3 시간 배양하였으며, 검은 반점이 생성되는 것을 확인한 다음, 상기 MTT 시약을 제거 후, DMSO를 100 μL 넣고 15-20 분 섞어준 후, 540 nm에서 흡광도 측정하여 세포의 생존률을 확인하는 결과를 도출하였다.After removing the MEM medium, 100 μL of MTT reagent (5 mg / mL in PBS) was added and incubated in a carbon dioxide atmosphere at 37 ° C. for 2-3 hours. After confirming that black spots were formed, the MTT reagent was removed, Were added and the mixture was mixed for 15-20 minutes. Then, the absorbance was measured at 540 nm to determine the survival rate of the cells.
흡광도
Absorbance
위의 표 6은 곤달비 추출물의 타크린 간손상 억제 측정 실험 결과를 나타낸 표이며, 도 2는 곤달비 추출물의 타크린 간손상 억제 측정 실험 결과를 나타낸 그래프이다.Table 6 shows the results of the test for inhibition of tacrine liver damage by the extract of Ganoderma lucidum, and FIG. 2 is a graph showing the results of the test for inhibition of tacrine liver damage by the Ganoderma extract.
표 6 및 도 2에 따르면, 곤달비 추출물을 투여한 셀의 흡광도가 간세포 및 타크린만 배양된 셀의 흡광도에 비하여 높은 것을 확인할 수 있으며, 농도가 높아질수록 흡광도가 높게 나타나 간세포의 생존율이 높아진 다는 것을 알 수 있으며, 이에 따라 곤달비 추출물의 간세포 손상 억제효능이 확인되었음을 알 수 있다. As shown in Table 6 and FIG. 2, it can be seen that the absorbance of cells treated with the extract of Ganoderma lucidum is higher than that of cells cultured only with hepatocytes and tacrine, and the higher the concentration, the higher the absorbance and the survival rate of hepatocytes Thus, it can be seen that the effect of the extract of Ganoderma lucidum against hepatocyte injury was confirmed.
앞서 설명한 본 발명의 상세한 설명에는 본 발명의 바람직한 실시예들을 참조하여 설명하였지만, 해당 기술분야의 숙련된 당업자 또는 해당 기술분야의 통상의 지식을 갖는 자라면 후술될 특허 청구범위에 기재된 본 발명의 사상 및 기술 영역으로부터 벗어나지 않는 범위 내에서 본 발명을 다양하게 수정 및 변경시킬 수 있을 것이다. While the present invention has been described in connection with what is presently considered to be practical exemplary embodiments, it is to be understood that the invention is not limited to the disclosed embodiments, but, on the contrary, It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit and scope of the invention.
Claims (12)
상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물인 것을 특징으로 하는 식품용 조성물.The method according to claim 1,
Wherein the extract is water, an organic solvent, or a mixed solvent thereof.
상기 추출물은 조성물 총 중량에 대하여 1~90 중량%로 포함되는 것을 특징으로 하는 식품용 조성물.The method according to claim 1,
Wherein the extract is contained in an amount of 1 to 90% by weight based on the total weight of the composition.
상기 식품은 차류, 음료류, 육류, 초코렛, 식품류, 과자류, 피자, 라면, 기타 면류, 껌류, 사탕류, 아이스크림류, 알코올 음료류, 비타민 복합제 및 건강보조식품류로 이루어진 군으로부터 선택되는 것을 특징으로 하는 조성물.The method according to claim 1,
Wherein the food is selected from the group consisting of tea, beverage, meat, chocolate, foodstuff, confectionery, pizza, ramen, other noodles, gums, candy, ice cream, alcoholic beverages, vitamin complexes and health supplements.
상기 조성물은 타크린(Tacrine) 또는 간손상을 유발하는 물질에 의한 간손상을 억제 또는 감소하는 활성을 갖는 것을 특징으로 하는 조성물.The method according to claim 1,
Wherein said composition has an activity of inhibiting or reducing liver damage by tacrine or a substance that causes liver damage.
상기 조성물은 항산화 효과를 갖는 것을 특징으로 하는 조성물.The method according to claim 1,
Wherein the composition has an antioxidant effect.
상기 추출물은 물, 유기용매 또는 이들의 혼합 용매 추출물인 것을 특징으로 하는 화장품용 조성물.8. The method of claim 7,
Wherein the extract is water, an organic solvent, or a mixed solvent extract thereof.
상기 추출물은 조성물 총 중량에 대하여 1~90 중량%로 포함되는 것을 특징으로 하는 화장품용 조성물.8. The method of claim 7,
Wherein the extract is contained in an amount of 1 to 90% by weight based on the total weight of the composition.
상기 화장품은 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 파우더, 오일, 분말 파운데이션, 유탁액 파운데이션, 왁스 파운데이션 및 스프레이로 이루어진 군으로부터 선택되는 것을 특징으로 하는 화장품용 조성물.8. The method of claim 7,
Wherein the cosmetic is selected from the group consisting of solutions, suspensions, emulsions, pastes, gels, creams, lotions, powders, oils, powder foundations, emulsion foundations, wax foundations and sprays.
상기 조성물은 항산화 효과를 갖는 것을 특징으로 하는 조성물. 8. The method of claim 7,
Wherein the composition has an antioxidant effect.
절단된 상기 곤달비를 30~35℃의 온도에서 36~48시간 동안 건조시키는 단계;
건조된 상기 곤달비를 분쇄하는 단계;
분쇄된 상기 곤달비를 추출하여 추출물로 제조하는 단계; 및
상기 추출물을 음료 첨가물들과 일정 비율로 혼합하여 음료를 제조하는 단계를 포함하는 숙취해소 음료제조방법.
Washing the gondolas, removing moisture and thinly cutting the gondolas;
Drying the cut sandwich at a temperature of 30 to 35 DEG C for 36 to 48 hours;
Crushing the dried khonatan;
Extracting the pulverized sandalwood to produce an extract; And
And mixing the extract with the beverage additives at a predetermined ratio to prepare a beverage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170124018A KR20190035139A (en) | 2017-09-26 | 2017-09-26 | A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170124018A KR20190035139A (en) | 2017-09-26 | 2017-09-26 | A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20190035139A true KR20190035139A (en) | 2019-04-03 |
Family
ID=66165603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170124018A KR20190035139A (en) | 2017-09-26 | 2017-09-26 | A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20190035139A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021182661A1 (en) * | 2020-03-13 | 2021-09-16 | 주식회사 네이처센스 농업회사법인 | Composition for improving antibacterial, anti-inflammatory, antiviral, and immune functions, comprising extract of ligularia stenocephala as active ingredient |
KR102520669B1 (en) * | 2021-12-17 | 2023-04-11 | 김명아 | Manufacturing method of Gulbi or Borigulbi containing perennial artemisia |
-
2017
- 2017-09-26 KR KR1020170124018A patent/KR20190035139A/en not_active Application Discontinuation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021182661A1 (en) * | 2020-03-13 | 2021-09-16 | 주식회사 네이처센스 농업회사법인 | Composition for improving antibacterial, anti-inflammatory, antiviral, and immune functions, comprising extract of ligularia stenocephala as active ingredient |
KR20210115381A (en) * | 2020-03-13 | 2021-09-27 | 주식회사 네이처센스 | Antimicrobial, anti-inflammatory, antiviral and immunologically enhancing composition comprising extract of ligularia stenocephala |
KR102520669B1 (en) * | 2021-12-17 | 2023-04-11 | 김명아 | Manufacturing method of Gulbi or Borigulbi containing perennial artemisia |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sumbul et al. | Myrtus communis Linn.-A review | |
KR101828584B1 (en) | Composition containing complex extracts including Veratrum nigrum var. ussuriense, Juglans mandshurica, Rodgersia podophylla and Chaenomeles sinensis with antioxidant activity or whitening | |
KR101817055B1 (en) | Food composition having anti-obesity, anti-cancer, anti-oxidative and immunity enhancing activities | |
TW201542213A (en) | Anti-obesity composition | |
KR101705547B1 (en) | Composition for antioxidant or anticancer or antidiabete or antimicrobial containing balloon flower extract | |
Yang et al. | The nutritional and bioactive components, potential health function and comprehensive utilization of pomegranate: a review | |
KR20180130080A (en) | Anti-inflammatory composition comprising extracts of grasses and preparing method thereof | |
KR20180011021A (en) | Pharmaceutical composition comprising extract of Clematis apiifolia DC. or Silene armeria L. for treating or prventing inflammatory disease | |
KR101794006B1 (en) | Anti inflammatory comprising plant extract | |
KR20190035139A (en) | A ccosmetic or food composition comprising ligularia senocephala extract and method of a hangover beverage using thereof | |
KR101125224B1 (en) | A composition for skin anti-aging comprising extracts or fractions of Eremochloa ophiuroides as an active ingredient | |
KR101964249B1 (en) | Composition for preventing, improving or treating atopic dermatitis comprising mixture of Torilis japonica extract and copper tripeptide-1 as effective component | |
KR101673204B1 (en) | Health beverage using natural materials with protection of brain cells | |
KR101768612B1 (en) | Food composition for improving liver function and method of health tea using thereof | |
Lim | Opuntia ficus-indica | |
KR101889331B1 (en) | A composition having anti-oxidation, anti-inflammation or anti-bacterial activity comprising Acanthopanax koreanum Nakai stem extracts, fractions thereof or compounds isolated therefrom as an active ingredient | |
Dhaka et al. | A Review on Botanical characteristics, Phytochemistry, Pharmacology and Traditional uses of selected Medicinal plants: Juniperus communis, Ficus carica, Garcinia indica | |
KR102154139B1 (en) | Composition comprising fermentation of sap of painted maple, cacao nibs extract and granat extract | |
KR20150037774A (en) | Preparation of clove having enhanced antioxidative effect | |
KR20190120860A (en) | Cosmetic compostion including extracts of fig leaves | |
KR102590758B1 (en) | Antioxidant or anti-inflammatory composition comprising extract of bilberry containing anthocyanidin components | |
KR20200084215A (en) | Anti-inflammatory composition comprising extract of Polyopes affinis | |
Iqbal et al. | Delving Into the Therapeutic Potential of Ficus Carica and Its Impact on Promoting Health: A Review | |
KR101440483B1 (en) | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient | |
KR101382412B1 (en) | Composition containing extract of bower actinidia which has antioxidant activity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |